FDA NDC Directory
Recently listed NDCs
Finished products in the FDA NDC Directory with the newest marketing start dates — new brands and generics, and new strengths or packages of existing products.
A listing is not an approval
The date shown is the marketing start date the labeler reported. Many new listings are generics, repackaged or relabeled products, or new package sizes. The marketing category (NDA, ANDA, BLA) on each product page says under what authority it is marketed.
Newest first
831 listings in the last 90 days
| Product | Strength | Form · route | Labeler | Listed | Product NDC |
|---|---|---|---|---|---|
| Raltegravir | Raltegravir potassium 600 mg/1 | Tablet, Film coatedOral | Lupin Pharmaceuticals, Inc. | Oct 14, 2026 | 70748-327 |
| Thiamine Hydrochloride | Thiamine hydrochloride 100 mg/mL | Injection, SolutionIntramuscular, Intravenous | NorthStar RxLLC | Oct 14, 2026 | 72603-565 |
| Glycerol Phenylbutyrate | Glycerol phenylbutyrate 1.1 g/mL | LiquidOral | PAI Holdings, LLC dba PAI Pharma | Oct 12, 2026 | 0121-1049 |
| calcium chloride | Calcium chloride 100 mg/mL | Injection, SolutionIntravenous | PAI Holdings, LLC dba PAI Pharma | Oct 12, 2026 | 0121-1099 |
| Lidocaine Hydrochloride | Lidocaine hydrochloride 10 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | Sandoz Inc. | Oct 12, 2026 | 0781-3537 |
| Lidocaine Hydrochloride | Lidocaine hydrochloride 20 mg/mL | Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural | Sandoz Inc. | Oct 12, 2026 | 0781-3539 |
| Vancomycin Hydrochloride | Vancomycin hydrochloride 5 g/100mL | Injection, Powder, Lyophilized, For solutionIntravenous | GLENMARK PHARMACEUTICALS INC., USA | Oct 12, 2026 | 68462-957 |
| Vancomycin Hydrochloride | Vancomycin hydrochloride 10 g/100mL | Injection, Powder, Lyophilized, For solutionIntravenous | GLENMARK PHARMACEUTICALS INC., USA | Oct 12, 2026 | 68462-958 |
| Trazodone HCL | Trazodone hydrochloride 50 mg/1 | TabletOral | Direct_Rx | Oct 12, 2026 | 72189-694 |
| Cyproheptadine Hydrochloride | Cyproheptadine hydrochloride 2 mg/1 | TabletOral | PANGEA PHARMACEUTICALS, LLC | Oct 12, 2026 | 81279-129 |
| Nafcillin | Nafcillin sodium 10 g/1 | Injection, Powder, For solutionIntravenous | ONESOURCE SPECIALTY PHARMA LIMITED | Oct 12, 2026 | 83270-316 |
| Trazodone Hydrochloride | Trazodone hydrochloride 100 mg/1 | TabletOral | American Health Packaging | Oct 11, 2026 | 60687-965 |
| Norethindrone and ethinyl estradiol | — | Kit | Apotex Corp. | Oct 10, 2026 | 60505-4901 |
| Mupirocin | Mupirocin calcium 20 mg/g | CreamTopical | Zydus Lifesciences Limited | Oct 10, 2026 | 70771-1981 |
| Mupirocin | Mupirocin calcium 20 mg/g | CreamTopical | Viona Pharmaceuticals Inc | Oct 10, 2026 | 72578-130 |
| Glipizide | Glipizide 5 mg/1 | TabletOral | AiPing Pharmaceutical, Inc. | Oct 9, 2026 | 11788-117 |
| Glipizide | Glipizide 10 mg/1 | TabletOral | AiPing Pharmaceutical, Inc. | Oct 9, 2026 | 11788-118 |
| Glipizide | Glipizide 2.5 mg/1 | TabletOral | AiPing Pharmaceutical, Inc. | Oct 9, 2026 | 11788-120 |
| Oseltamivir Phosphate | Oseltamivir phosphate 75 mg/1 | CapsuleOral | REMEDYREPACK INC. | Oct 9, 2026 | 70518-4770 |
| Glipizide | Glipizide 5 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | Oct 9, 2026 | 72789-579 |
| Glipizide | Glipizide 10 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | Oct 9, 2026 | 72789-580 |
| Tofacitinib | Tofacitinib citrate 5 mg/1 | Tablet, Film coatedOral | XLCare Pharmaceuticals Inc | Oct 9, 2026 | 72865-366 |
| Tofacitinib | Tofacitinib citrate 10 mg/1 | Tablet, Film coatedOral | XLCare Pharmaceuticals Inc | Oct 9, 2026 | 72865-367 |
| Neomycin and Polymyxin B sulfates and Hydrocortisone OTICneomycin and polymyxin b sulfates and hydrocortisone | Neomycin sulfate 3.5 mg/mL + 2 more ingredients | Solution/ dropsAuricular (Otic) | Hikma Pharmaceuticals USA Inc. | Oct 8, 2026 | 0054-0975 |
| divalproex sodium | Divalproex sodium 250 mg/1 | Tablet, Film coated, Extended releaseOral | Coupler LLC | Oct 8, 2026 | 67046-1696 |